3 views left Get unlimited views with a free account

Subscribe to GlobalData Explorer

Take your business to the next level. Explore the latest trends and actionable insights to inform business strategy and pinpoint opportunities and risks.

Number of ongoing Clinical Trials (for drugs) involving Anosmia by Phase

Industry: Pharmaceuticals
Current: Other Industry Indicators

There are currently 12 ongoing clinical trials involving Anosmia
Of the 12 trials,5 trials are in Phase II
Furthermore, 3 trials are in Phase IV

Number of ongoing Clinical Trials (for drugs) involving Anosmia by Phase

View as table

The global pharmaceutical industry is steadily developing new drugs for Anosmia, a Central Nervous System indication. The highest number of ongoing clinical trials involving Anosmia is in North America. The Middle East and Africa and Asia-Pacific are among some of the other prominent regions involved in Anosmia-related drug trials.

Icahn School of Medicine at Mount Sinai: The leading ongoing Anosmia-related clinical trials sponsor

Icahn School of Medicine at Mount Sinai, the United States of America-based private institute, is the top sponsor for Anosmia-related ongoing clinical trials.

Beijing Children's Hospital, Deraya University, ClinAmygate, University of Pittsburgh, and Bagheiat-Allah University of Medical Sciences are a few other notable sponsors involving Anosmia.

A clinical trial sponsor can be a Company, Government, Individual, or Institution.